Inventor · disambiguated record
Mathias Krusch
Also filed as: KRUSCH MATHIAS
10 granted patents·11 pending applications·47 citations·filing 2010–2025
87Inventor score
Files withASCENDIS PHARMA BONE DISEASES AS16ASCENDIS PHARMA AS2RAU HARALD2ASCENDIS PHARMA OSTEOARTHRITIS DIV A/S1
Top patents by PatentIndex Score
21 records- 0196US11890326B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Feb 6, 2024·5 cites·11 claims
- 0296US11793861B2PTH prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Oct 24, 2023·5 cites·15 claims
- 0395US11918628B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Granted Mar 5, 2024·4 cites·9 claims
- 0495US11857603B2PTH compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Jan 2, 2024·5 cites·12 claims
- 0592US11759504B2PTH compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Granted Sep 19, 2023·6 cites·12 claims
- 0689US9173953B2Prodrugs containing an aromatic amine connected by an amido bond to a linkerRAU HARALD·Filed 2010·Granted Nov 3, 2015·22 cites·20 claims
- 0789US2025268988A1PTH ProdrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2024·Application pending·0 cites
- 0887US12295989B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2024·Granted May 13, 2025·0 cites·5 claims
- 0987US12214020B2PTH prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Granted Feb 4, 2025·0 cites·9 claims
- 1081US2023321198A1Dosage Regimen for a Controlled-Release PTH CompoundASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Application pending·0 cites
- 1180US2024173385A1PTH Compounds with Low Peak-To-Trough RatiosASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Application pending·0 cites
- 1277US2022008516A1PTH ProdrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2021·Application pending·0 cites
- 1377US2025302924A1Controlled-Release PTH CompoundASCENDIS PHARMA BONE DISEASES AS·Filed 2025·Application pending·0 cites
- 1471US2020360487A1Pth prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2020·Application pending·0 cites
- 1571US2020376089A1Pth prodrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2020·Application pending·0 cites
- 1662US2023123784A1Biodegradable Polyethylene Glycol Based Water-Insoluble HydrogelsASCENDIS PHARMA AS·Filed 2022·Application pending·0 cites
- 1761US2020276276A1PTH ProdrugsASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Application pending·0 cites
- 1850US2018042996A1Hydrogel-Linked IL-1ra ProdrugASCENDIS PHARMA OSTEOARTHRITIS DIV A/S·Filed 2014·Application pending·0 cites
- 1949US2019262426A1Hydrogel-Linked IL-1ra ProdrugASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 2048US12453778B2Incremental dose finding in controlled-release PTH compoundsASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Granted Oct 28, 2025·0 cites·8 claims
- 2143US11559482B2Biodegradable polyethylene glycol based water-insoluble hydrogelsRAU HARALD·Filed 2010·Granted Jan 24, 2023·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Mathias Krusch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →